LVAD versus CIED Infections: Distinct Entities, Distinct Suppression Strategies

Supavit Chesdachai; Larry M Baddour; Daniel C DeSimone

doi:10.1093/cid/ciae647

LVAD versus CIED Infections: Distinct Entities, Distinct Suppression Strategies

Clin Infect Dis. 2024 Dec 24:ciae647. doi: 10.1093/cid/ciae647. Online ahead of print.

Authors

Supavit Chesdachai¹, Larry M Baddour^{1

2}, Daniel C DeSimone^{1

2}

Affiliations

¹ Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 39718372
DOI: 10.1093/cid/ciae647

Abstract

A distinction between infections of left ventricular assist devices (LVADs) and cardiac implantable electronic devices (CIEDs) is warranted as they differ markedly in incidence, microbiologic profiles, clinical presentations, and extraction feasibility. These differences necessitate tailored suppressive antibiotic therapy (SAT) strategies. This commentary highlights the need for device-specific SAT approaches.

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.